학술논문
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy
Document Type
Article
Author
Jimenez-Fonseca, P.; Foy, V.; Raby, S.; Carmona-Bayonas, A.; Macía-Rivas, L.; Arrazubi, V.; Cacho Lavin, D.; Hernandez San Gil, R.; Custodio, A.; Cano, J.M.; Fernández Montes, A.; Mirallas, O.; Macias Declara, I.; Vidal Tocino, R.; Visa, L.; Limón, M.L.; Pimentel, P.; Martínez Lago, N.; Sauri, T.; Martín Richard, M.; Mangas, M.; Gil Raga, M.; Calvo, A.; Reguera, P.; Granja, M.; Martín Carnicero, A.; Hernández Pérez, C.; Cerdá, P.; Gomez Gonzalez, L.; Garcia Navalon, F.; Pacheco Barcia, V.; Gutierrez Abad, D.; Ruiz Martín, M.; Weaver, J.; Mansoor, W.; Gallego, J.
Source
In: Therapeutic Advances in Medical Oncology . (Therapeutic Advances in Medical Oncology, January-December 2023, 15)
Subject
Language
English
ISSN
17588359
17588340
17588340